Literature DB >> 21601274

Extended release of high molecular weight hydroxypropyl methylcellulose from molecularly imprinted, extended wear silicone hydrogel contact lenses.

Charles J White1, Matthew K McBride, Kayla M Pate, Arianna Tieppo, Mark E Byrne.   

Abstract

Symptoms of contact lenses induced dry eye (CLIDE) are typically treated through application of macromolecular re-wetting agents via eye drops. Therapeutic soft contact lenses can be formulated to alleviate CLIDE symptoms by slowly releasing comfort agent from the lens. In this paper, we present an extended wear silicone hydrogel contact lens with extended, controllable release of 120 kDa hydroxypropyl methylcellulose (HPMC) using a molecular imprinting strategy. A commercial silicone hydrogel lens was tailored to release approximately 1000 μg of HPMC over a period of up to 60 days in a constant manner at a rate of 16 μg/day under physiological flowrates, releasing over the entire range of continuous wear. Release rates could be significantly varied by the imprinting effect and functional monomer to template ratio (M/T) with M/T values 0, 0.2, 2.8, 3.4 corresponding to HPMC release durations of 10, 13, 23, and 53 days, respectively. Lenses had high optical quality and adequate mechanical properties for contact lens use. This work highlights the potential of imprinting in the design and engineering of silicone hydrogel lenses to release macromolecules for the duration of wear, which may lead to decreased CLIDE symptoms and more comfortable contact lenses.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601274     DOI: 10.1016/j.biomaterials.2011.04.044

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

1.  Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.

Authors:  Guoting Qin; Zhiling Zhu; Siheng Li; Alison M McDermott; Chengzhi Cai
Journal:  Biomaterials       Date:  2017-01-31       Impact factor: 12.479

2.  Extended release of ketotifen from silica shell nanoparticle-laden hydrogel contact lenses: in vitro and in vivo evaluation.

Authors:  Furqan A Maulvi; Mayurkumar A Mangukiya; Prachi A Patel; Rutvi J Vaidya; Akshay R Koli; Ketan M Ranch; Dinesh O Shah
Journal:  J Mater Sci Mater Med       Date:  2016-05-13       Impact factor: 3.896

3.  Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery.

Authors:  Heidi R Culver; John R Clegg; Nicholas A Peppas
Journal:  Acc Chem Res       Date:  2017-02-07       Impact factor: 22.384

4.  Controlled Release of Multiple Therapeutics from Silicone Hydrogel Contact Lenses.

Authors:  Charles James White; Stephen Anthony DiPasquale; Mark Edward Byrne
Journal:  Optom Vis Sci       Date:  2016-04       Impact factor: 1.973

5.  Development of an In Vitro Ocular Platform to Test Contact Lenses.

Authors:  Chau-Minh Phan; Hendrik Walther; Huayi Gao; Jordan Rossy; Lakshman N Subbaraman; Lyndon Jones
Journal:  J Vis Exp       Date:  2016-04-06       Impact factor: 1.355

6.  Development of an Eye Model With a Physiological Blink Mechanism.

Authors:  Chau-Min Phan; Hendri Walther; Ha Qiao; Ra Shinde; Lyndo Jones
Journal:  Transl Vis Sci Technol       Date:  2019-09-03       Impact factor: 3.283

7.  Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma.

Authors:  Feng Yan; Yanxia Liu; Shulan Han; Qingsong Zhao; Nannan Liu
Journal:  AAPS PharmSciTech       Date:  2020-01-13       Impact factor: 4.026

8.  In vivo drug delivery via contact lenses: The current state of the field from origins to present.

Authors:  Liana D Wuchte; Stephen A DiPasquale; Mark E Byrne
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-18       Impact factor: 5.062

Review 9.  Nanomedicine approaches for corneal diseases.

Authors:  Shyam S Chaurasia; Rayne R Lim; Rajamani Lakshminarayanan; Rajiv R Mohan
Journal:  J Funct Biomater       Date:  2015-04-30

Review 10.  Nanotechnology approaches for ocular drug delivery.

Authors:  Qingguo Xu; Siva P Kambhampati; Rangaramanujam M Kannan
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.